Loading clinical trials...
Loading clinical trials...
This retrospective, prospective observational study aims to evaluate the epidemiology and rate of anterior cruciate ligament re- rupture after surgery in patients treated from January 2020 to December...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
NCT07049484 · ACL Reconstruction, Tenodesis, and more
NCT07480057 · Chronic Liver Disease and ACLF
NCT05501210 · Anterior Cruciate Ligament Injuries, Anterior Cruciate Ligament Rupture, and more
NCT07470359 · ACL Reconstruction, Intraarticular Injection, and more
NCT07386327 · Infraclavicular Brachial Plexus Block, Dextrose, and more
IRCCS Istituto Ortopedico Galeazzi
Milan
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions